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Abstract
Epstein-Barr virus (EBV) is an oncogenic γ-herpes virus associated with malignancies that 
develop in both lymphoid and epithelial cells including nasopharyngeal carcinoma (NPC). The 
EBV protein latent membrane protein 2A (LMP2A) is expressed in NPC and can modulate 
epithelial proliferation, transformation, and differentiation, and as such, may promote malignancy. 
A key regulator of epithelial cell differentiation is the transcription factor p63, a member of the 
p53 family. This study examines the potential contribution of p63 to LMP2A-mediated inhibition 
of epithelial differentiation. Stable expression of LMP2A increased the protein level and stability 
of the ΔNp63α isoform, and in two epithelial cell lines, LMP2A interacted with ΔNp63α under 
stable and transient expression systems. LMP2A and ΔNp63α were localized to the cytoplasm and 
nuclear membrane and co-immunoprecipitated in the same fractions. Following induction of 
epithelial cell differentiation by calcium, expression of differentiation markers was impaired in 
both ΔNp63α and LMP2 expressing cells. Induction of p63α, association of p63α with LMP2A, 
and impairment of differentiation required the PY and ITAM signaling motif of LMP2A. By 
associating with and being regulated by LMP2A,ΔNp63α may function as a unique regulator of 
LMP2A effects on epithelial differentiation and contribute to EBV-associated epithelial cancers.
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Introduction
Epstein-Barr virus (EBV) is an oncogenic γ-herpes virus associated with several 
malignancies including Burkitt’s lymphoma, Hodgkin’s lymphoma and nasopharyngeal 
carcinoma (NPC) (Brooks et al., 1992; Busson et al., 1992; Raab-Traub, 1992a; Raab-Traub, 
1992b; Raab-Traub, 2002; Young & Rowe, 1992). Most individuals are infected early in life 
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and develop life-long latency, with some primary infections inducing infectious 
mononucleosis. Although primarily B-cell tropic, EBV infects other cell types, such as 
epithelial cells, and is considered a major factor in the development of nasopharyngeal 
carcinoma (NPC) (Brooks et al., 1992; Busson et al., 1992; Raab-Traub, 1992a; Raab-Traub, 
1992b). There are at least 3 different gene expression patterns in latently infected cells, 
Latency I, II, and III. Many of the EBV-associated cancers including NPC and Hodgkin’s 
lymphoma have the EBV latency pattern II, characterized by expression of the nuclear 
protein EBNA-1 and the membrane proteins latent membrane protein 1 and 2 (LMP1 and 
LMP2) (Brooks et al., 1992; Busson et al., 1992; Raab-Traub, 1992a; Raab-Traub, 1992b). 
LMP2A mimics B-cell receptor signaling to promote cell survival and proliferation of B-
cells (Merchant et al., 2001). In epithelial cells, LMP2A can induce transformation, promote 
motility, and inhibit differentiation, all functions that can promote malignant cell growth 
(Bultema et al., 2009; Fukuda & Longnecker, 2007; Scholle et al., 2000). One of the key 
regulators of epithelial cell development and differentiation is the transcription factor p63.
p63 is member of the p53 family of transcription factors and is preferentially expressed in 
epithelial cells (Candi et al., 2008; Candi et al., 2007; Medawar et al., 2008; Murray-
Zmijewski et al., 2006; Ogawa et al., 2008; Truong & Khavari, 2007). p63 exists as 6 
distinct isoforms generated by two different promoters, to produce TAp63 and ΔNp63, and 
C-terminal alternative splicing, to produce TAp63α, ΔNp63α, TAp63β, ΔNp63β, TAp63γ, 
and ΔNp63γ. The TAp63 isoforms contain an N-terminal transactivating domain missing in 
ΔNp63α, consequently TAp63 has traditionally been considered an activating transcription 
factor (Candi et al., 2008; Candi et al., 2007; Medawar et al., 2008; Murray-Zmijewski et al., 
2006; Ogawa et al., 2008; Truong & Khavari, 2007). The isoforms can be distinguished by 
their molecular weights (MW) such that all of the TA isoforms are approximately 10 kd 
larger than the corresponding ΔN isoform. Recently, ΔNp63α has been demonstrated to be 
the main p63 isoform expressed in keratinocytes and has been shown to be essential for 
epithelial development and differentiation (Candi et al., 2008; Koster et al., 2004). ΔNp63α 
is highly expressed in basal, proliferating keratinocytes and is associated with inhibition of 
terminal differentiation marker expression as cells progress through the differentiation 
pathway (Bamberger et al., 2002; Candi et al., 2008; Ogawa et al., 2008). In addition, 
ΔNp63 expression has been detected in human malignancies including NPC and may 
participate in disease pathogenesis by promoting cell proliferation and inhibiting 
differentiation (Candi et al., 2007; Guo et al., 2006; Okuyama et al., 2007; Truong & 
Khavari, 2007; Yip & Tsao, 2008).
To evaluate the potential role of p63 in LMP2A-mediated inhibition of differentiation, p63 
expression was determined in epithelial cells expressing LMP2A and in cells induced to 
differentiate. The data indicate that LMP2A increased the expression levels and stability of 
ΔNp63α, and physically associated with ΔNp63α at the nuclear membrane. Both p63 and 
LMP2A- impaired expression of the differentiation markers involucrin, keratin 1, and 
keratin 10. The effects on p63 and inhibition of differentiation by LMP2A required the PY 
and ITAM signaling motifs.
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LMP2A Induces Expression and Stability of p63α in Epithelial Cells
Several signaling motifs have been identified in LMP2A including a potential src kinase 
binding site (YEEA), an immunoreceptor tyrosine-based activation motif (ITAM) that binds 
the Syk tyrosine kinase, and two PY motifs that bind WW domain-containing ubiquitin 
ligases. LMP2A has previously been shown to inhibit differentiation in epithelial cells and 
the PY motif is required for the inhibition of involucrin expression upon differentiation in 
human foreskin keratinocytes (Morrison & Raab-Traub, 2005; Scholle et al., 2000). The 
ubiquitin ligase Itch interacts with the LMP2A PY motifs and regulates degradation of 
LMP2A and LMP2A-associated signaling mediators (Ikeda et al., 2003; Ikeda et al., 2000; 
Longnecker et al., 2000; Rossi et al., 2006a; Rossi et al., 2006b). One target of Itch is p63, a 
transcription factor belonging to the p53 family, that has been identified as a key regulator 
of epithelial cell growth and differentiation (Candi et al., 2008; Candi et al., 2007; Medawar 
et al., 2008; Murray-Zmijewski et al., 2006; Ogawa et al., 2008; Truong & Khavari, 2007). 
ΔNp63α is associated with impaired epithelial cell differentation and with nasopharyngeal 
carcinoma, and as such may provide a key target for LMP2A signaling. To determine 
whether LMP2A affects ΔNp63α, its expression and stability were studied in HaCaT cells 
stably expressing LMP2A.
Using antibody specific for total p63α, immunoblotting of whole cell lysates revealed that 
LMP2A increased the protein levels of an approximately 72 kd protein, compared to pBabe, 
consistent with the size of ΔNp63α (Figure 1A). Antibody specific for ΔNp63 indicated that 
the 72 kd protein was ΔNp63α and quantitation relative to actin indicated that LMP2 
increased the levels approximately 50% (Figure 1A, B). The LMP2A-induced increase in 
ΔNp63α expression was impaired by mutation of the LMP2A PY motifs or by deletion of 
the ITAM motif (Figure 1A, B). In contrast, the YEAA motif did not impair the increased 
ΔNp63α expression. The ITAM mutant that also lacks one PY domain was consistently 
expressed at higher levels perhaps reflecting its impaired activity and interaction with 
ubiquitin ligases. These findings suggest that the LMP2A-induced increase in ΔNp63α 
levels required PY and ITAM. Quantitative RT-PCR that distinguished the two distinct 
amino terminal forms revealed that the ΔNp63 isoform was predominant in HaCaT cells 
with essentially no expression of TAp63 (Figure 1C), further implicating ΔNp63α as the 
isoform targeted by LMP2A. Importantly, LMP2A did not increase the relative transcription 
of either form (data not shown), suggesting that ΔNp63α regulation by LMP2A was post-
transcriptional.
To determine the effect of LMP2A on p63α protein stability, HaCaT cells expressing pBabe 
or LMP2A were treated with cycloheximide to inhibit protein synthesis, and p63α 
expression was determined by western blot. pBabe cells had a time-dependent decrease in 
p63α expression while in LMP2A cells, p63α expression did not decrease in the presence of 
a protein synthesis inhibitor, suggesting LMP2A increased the expression p63α through 
effects on its stability (Figure 1D, E). A half-life for p63α in LMP2A cells could not be 
calculated because a slight increase in p63α expression relative to actin from time 0 to 24 
hours gave a line of best fit with a positive slope, indicating no degradation of p63α (Figure 
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1E). LMP2A expression decreased in a time-dependent manner following cycloheximide 
treatment indicating that LMP2A did not impair the protein degradation machinery in 
HaCaT cells (Figure 1D). The increased stability of ΔNp63α has also been described in NPC 
cell lines (Guo et al., 2006)
To determine if LMP2A-induced p63α protein stability was caused by impaired proteasome-
mediated degradation, pBabe and LMP2A expressing cells were treated with the proteasome 
inhibitor MG132. In pBabe cells, treatment with MG132 increased p63α expression 
compared to treatment with the DMSO vehicle control to levels equivalent to those in 
LMP2A expressing cells indicating that p63α is regulated by proteasome-mediated 
degradation (Figure 1F). In contrast, p63α levels in LMP2A cells were unchanged when 
treated with MG132 compared with DMSO and were similar to p63α levels in pBabe cells 
treated with MG132 (Figure 1F). These findings suggest that LMP2A impairs proteasome-
mediated degradation of p63α in pBabe cells (Figure 1F). The Itch ubiquitin ligase that is 
known to regulate p63 was increased by LMP2A and inhibition of the proteasome did not 
affect Itch levels (Figure 1F).
LMP2A and p63α Interact in Cytoplasmic and Nuclear Membrane Fractions in Epithelial 
Cells
To assess the effects of LMP2A on the subcellular localization of Itch and p63α, HaCaT 
cells stably expressing LMP2A, LMP2A mutants, and ΔNp63α were fractionated into 
cytoplasm, nucleoplasm, and nuclear membrane. Protein expression was determined by 
western blot (Figure 2A) and the levels of the specific proteins in each fraction are presented 
as % of the total individual protein with standard error calculated from 3 or more 
experiments (Figure 2B, C, D). The purity of the fractions was determined using the 
endoplasmic reticulum marker GRP78 and the nuclear membrane marker emerin (data not 
shown). In the pBabe vector control cell, Itch was predominantly detected in the cytoplasm 
and nucleoplasm fractions with low expression detected in the nuclear membrane (Figure 
2A, B). Stable expression of LMP2A, PY, YEEA, or ΔNp63α did not affect Itch localization 
or levels, however loss of the ITAM motif decreased cytoplasmic and increased nuclear 
expression of Itch (Figure 2A, B).
In the vector control cells, p63α localized primarily to the cytoplasm and nuclear membrane 
fractions (Figure 2A, C). Stable expression of LMP2A, PY, ITAM, YEEA, or ΔNp63α did 
not significantly affect p63 localization (Figure 2A, C). However, the low levels of 
expression of p63α in pBabe, ITAM, and ΔNp63α cells compared with LMP2A-induced 
expression required longer exposures to detect bands for quantitation (Figure 2A, C). The 
lower overall expression of p63α in pBabe and ITAM cells was consistent with the lower 
expression detected in whole cell lysates (Figure 1A). Full length LMP2A and all LMP2A 
mutants were predominately cytoplasmic with some expression in the nuclear membrane 
fraction (Figure 2A, D).
To determine the potential interaction of LMP2A and p63α, LMP2A was 
immunoprecipitated using cytoplasm from the pBabe control cells and from the cytoplasm, 
nucleoplasm, and nuclear membranes from LMP2A expressing HaCaT cells. Itch and p63α 
were detected with LMP2A precipitated from the cytoplasm and nuclear membrane (Figure 
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2E). Neither Itch nor p63α were detected in the immunoprecipitated material from the 
pBabe lysates with the LMP2 antibody or by using beads alone in the absence of antibody 
indicating that their precipitation required LMP2 and did not reflect a non-specific 
interaction of Itch or p63α with the LMP2 antibody. These findings indicate that LMP2A 
interacts with endogenous p63 and confirm the interaction of LMP2A and Itch that has been 
previously described (Ikeda et al., 2003; Ikeda et al., 2000; Longnecker et al., 2000).
The ability of LMP2A to interact with the ΔNp63α isoform was evaluated in HEK293 cells, 
that do not endogenously express detectable levels of p63α (data not shown), transfected 
with an expression construct for ΔNp63α. Endogenous Itch was detected in the cytoplasm, 
nucleoplasm, and nuclear membrane of the vector control HEK293 cells (Figure 3A, B). 
Transiently expressed LMP2A was predominantly detected in the nuclear membrane 
compared to the stably expressing LMP2A HaCaT cells. Localization of transiently 
expressed ΔNp63α was also localized primarily to the nuclear membrane with equivalent 
levels of detection in the cytoplasm and nucleoplasm (Figure 3A, C). The different 
localization of ΔNp63α and LMP2A in transient and stable expression systems suggests that 
initial protein expression is detected at the nuclear membrane, whereas stably expressed or 
endogenous proteins associate with cytoplasmic components. Surprisingly, the relative 
levels of nuclear ΔNp63α decreased in the presence of LMP2A.
The interaction of ΔNp63α with Itch and LMP2 was evaluated in the cytoplasm, 
nucleoplasm, and nuclear membrane fractions of the transiently transfected HEK293 cells. 
Itch interacted withΔNp63α in the nuclear membrane where ΔNp63α was predominantly 
expressed (Figure 3E). Similarly, LMP2A also interacted with ΔNp63α at the nuclear 
membrane. While protein localization differed in transient and stable expression systems, 
LMP2A and ΔNp63α interacted under both conditions.
To determine which signaling motifs were required for the interaction of LMP2A with 
p63α, LMP2A was immunoprecipitated from HEK293 cells transiently expressing full-
length or mutated LMP2A. ΔNp63α was detected at equivalent levels with 
immunoprecipitated LMP2A or LMP2A with the mutated YEEA motif but was significantly 
decreased with the PY and ITAM mutations (Figure 3F). Similarly, the interaction of Itch 
with LMP2A also required the PY and ITAM motifs (Figure 3F). The decreased 
immunoprecipitation of both ΔNp63α and Itch with these LMP2 mutants confirmed that Itch 
and ΔNp63α do not nonspecifically precipitate with the LMP2A antisera. The low level of 
Itch detected with LMP2A likely reflects that only a subset of the total Itch is present in the 
nuclear membrane where LMP2A is predominantly detected. The requirement of PY and 
ITAM for both interactions suggests that p63α, Itch, and LMP2A may exist as a complex.
LMP2A Co-Localizes with p63α
The potential interaction of LMP2A and p63α was also evaluated in HEK293 cells 
transiently expressing LMP2A and ΔNp63α, and in HaCaT cells stably expressing LMP2A, 
using immunofluorescent staining to identify colocalization. In HEK293 cells (Figure 4, 
panels ii through iv), LMP2A and p63α colocalized with striking perinuclear staining 
confirming the cell fractionation and co-immunoprecipitation analyses (Figure 3). Similarly, 
LMP2A and endogenous p63α primarily had perinuclear co-localization in HaCaT cells, 
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suggesting they interact at the nuclear membrane, with some interaction evident in the 
cytoplasm (Figure 4 panels vi-viii). The less intense staining of both LMP2A and p63α in 
HaCaT cells is likely a consequence of more uniform, stable, and less abundant expression 
of these proteins, whereas both proteins were transiently expressed in HEK293 cells and 
stained 48 hours following transfection. Background staining with FITC-anti-rat or Cy3-
anti-mouse antibodies was not detected in either HEK293 cells or HaCaT cells (Figure 4 
panels ix–xii).
LMP2A Impairs Epithelial Cell Differentiation Induced by Calcium
To determine the effects of LMP2A and ΔNp63α on epithelial cell differentiation, HaCaT 
cells were grown for 3 weeks in calcium-free DMEM to decrease differentiation. In the 
original calcium-containing growth media, HaCaT cells expressed high levels of the early 
differentiation marker keratin 10 and the intermediate differentiation marker involucrin 
(Figure 5A, day –5). Following treatment for 3 weeks without calcium, HaCaT cells with or 
without LMP2A acquired an undifferentiated morphology (data not shown; (Deyrieux & 
Wilson, 2007)) with reduced levels of keratin 10 and involucrin (Figure 5A). The relative 
levels of keratin 10 and involucrin relative to GAPDH confirmed this decrease and indicated 
that LMP2A did not significantly affect the expression of these markers in de-differentiated 
cells (Figure 5B).
It is known that differentiation can be induced in proliferating keratinocytes by exposure to 
calcium. The effects on expression of keratin 10 and involucrin mRNA in response to the 
addition of 2.8mM CaCl2 to the growth media of the de-differentiated HaCaT cells were 
determined. HaCaT pBabe cells had a slight time dependent increase in calcium-induced 
mRNA expression of the early differentiation marker keratin 1 (Figure 5C) and a clear 
induction of mRNA for the intermediate differentiation marker involucrin (Figure 5D). 
Whereas expression of the early marker keratin 1 peaked at 48 hours, expression of the 
intermediate marker involucrin continued to increase for 96 hours in pBabe cells. In 
contrast, the mRNA for keratin 1 and involucrin in HaCaT LMP2A cells decreased in 
response to calcium and remained low over the duration of the experiment (Figure 5C, D). 
Interestingly, LMP2A expressing cells had higher mRNA levels for both markers at time 
zero, in particular for the early marker keratin 1, although the difference in involucrin was 
not at the protein level (Figure 5A, day 21). Involucrin protein expression increased in 
response to calcium over time in the pBabe control cells, however this induction of 
involucrin was impaired in cells stably expressing LMP2A confirming the decreased 
expression of involucrin mRNA (Figure 5E). The impaired induction of the differentiation 
markers keratin 1 and involucrin in the presence of LMP2A confirms that LMP2 inhibits 
differentiation (Figure 5E). Similarly, involucrin was not induced in HaCaT cells that stably 
expressed ΔNp63α indicating that ΔNp63α expression can mimic the effect of LMP2A on 
calcium-induced differentiation. Calcium-induced involucrin expression in the PY mutant 
was similar to that observed in pBabe cells, confirming that the PY motif is required for the 
inhibition of differentiation by LMP2A (Figure 5E) (Morrison and Raab-Traub, 2005).
To determine whether LMP2A-induced ΔNp63α was associated with the state of 
differentiation of epithelial cells, p63α protein expression was determined by western blot in 
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HaCaT cells, normalized to actin, prior to de-differentiation and following de-differentiation 
(Fig. 5F). The p63α protein levels were slightly lower in LMP2A compared to pBabe cells 
prior to de-differentiation (Figure 5F), suggesting that LMP2A does not induce p63α or 
promote a de-differentiated phenotype when it is expressed in differentiated cells. However, 
LMP2A clearly induced ΔNp63α in the de-differentiated cells and both LMP2A and 
ΔNp63α inhibited expression of differentiation markers after exposure to calcium. The 
ability of LMP2A to induce expression of ΔNp63α was impaired with mutation of the PY or 
ITAM signaling motifs (Figure 5F). This data supports LMP2A-induced p63α as a mediator 
for inhibiting keratinocyte progress through the calcium-induced differentiation pathway.
Discussion
The findings in this study reveal that in epithelial cells, expression of EBV latent membrane 
protein 2A (LMP2A) increased the protein levels and stability of p63α and physically 
associated with p63α in the cytoplasm and at the nuclear membrane. Both LMP2A and 
ΔNp63α impaired cellular differentiation induced by calcium and the effects of LMP2A on 
p63α and intermediate differentiation marker expression required the PY motifs. These 
findings confirm previous findings that LMP2A-induced inhibition of involucrin in 
epithelial cells was dependent on its PY motif (Morrison & Raab-Traub, 2005; Scholle et al., 
2000). This is the first study to identify effects of LMP2A on p63α and to identify the 
requirement for specific LMP2A signaling motifs in regulating ΔNp63α.
It is known that p63α protein levels can be regulated through ubiquitination mediated by the 
ubiquitin ligase Itch that physically associates with p63α (Melino et al., 2006). Itch also 
associates with other target proteins, including LMP2A, through interaction of the Itch WW 
domain with the target protein PY domain (Ikeda et al., 2003; Ikeda et al., 2000; Ikeda et al., 
2001; Longnecker et al., 2000; Winberg et al., 2000). The data presented here suggest that 
LMP2A can modulate the effects of Itch on ΔNp63α resulting in increased protein levels. 
LMP2A co-immunoprecipitated with Itch and this complex was detected only in the 
cytoplasm and nuclear membrane. Similarly, LMP2A-co-immunoprecipitated with ΔNp63α 
in the cytoplasm and nuclear membrane, suggesting the possibility that LMP2A, ΔNp63α, 
and Itch form a complex.
The interaction of LMP2A with p63α required both the PY and the ITAM signaling 
domains of LMP2A as either mutant reduced complex formation. As expected, Itch was 
unable to interact with LMP2A in the presence of the PY mutation. The ITAM was also 
required for the interaction of Itch and LMP2A, although this may reflect that the ITAM 
deletion mutant is also missing a PY domain. It is unknown if p63α directly binds to the PY 
or ITAM motifs of LMP2. p63α contains PY domains that can bind Itch and a sterile α 
motif (SAM) that could interact with the SH2 domains of Syk, leading to the possibility that 
p63α interacts with LMP2A via Itch and/or Syk as signaling mediators or as scaffold 
proteins. A recent study revealed that after induction of DNA damage, the stability of 
ΔNp63 was decreased due to its interaction with RACK1 and that the RACK1 effects were 
blocked by the interaction of ΔNp63 with Stxbp4 (Li et al., 2009). LMP2A may affect the 
expression of additional proteins that regulate p63 stability such as Stxbp4 or RACK1.
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Both LMP2A and ΔNp63α inhibited expression of the intermediate epithelial differentiation 
marker involucrin suggesting that ΔNp63 may, in part, mediate the effect of LMP2A on 
differentiation. LMP2A is expressed in the epithelial cancer nasopharyngeal carcinoma 
(Busson et al., 1992) and by promoting transformation, motility, and inhibiting 
differentiation, LMP2A has been implicated in promoting epithelial malignancy (Fukuda & 
Longnecker, 2007; Scholle et al., 2000). ΔNp63α is expressed at high levels in NPC 
suggesting that its stabilization by LMP2A may be a contributing factor to the 
undifferentiated state of NPC. ΔNp63α has also been shown to affect the transcription of 
several target genes including those encoding cell cycle proteins (Candi et al., 2007; Testoni 
& Mantovani, 2006; Wu et al., 2003). It is presently unknown if ΔNp63α is active as a 
transcription factor in the presence of LMP2A. ΔNp63α was barely detected in the 
nucleoplasm in fractionated cells but nuclear ΔNp63α was detectable by immunostaining. 
However, in an initial microarray analysis several previously identified transcriptional 
targets of ΔNp63α were upregulated in LMP2A-expressing cells including matrilin-2, Dlx3, 
and IL-8 (data not shown). This may indicate that ΔNp63α is transcriptionally active in the 
presence of LMPA and could potentially regulate expression of genes involved in the 
regulation of differentiation. It is known that ΔNp63α inhibits p21 expression, a gene that is 
required for keratinocyte terminal differentiation (Candi et al., 2007; Westfall et al., 2003).
It is intriguing that LMP2A regulates a protein so integral to epithelial function and 
differentiation. Although ΔNp63α inhibits expression of terminal differentiation markers 
like involucrin, it is also essential for the initiation of differentiation and of early 
differentiation markers like keratin 1 (Ogawa et al., 2008). This recent finding may explain 
why LMP2A cells had approximately 4-fold higher mRNA levels of keratin 1 compared to 
pBabe vector control cells. In addition, pBabe and LMP2A cells had similar morphological 
changes in response to calcium (data not shown), suggesting that the initiation of the 
differentiation program was not impaired by LMP2A. These findings are consistent with the 
effects of LMP2A on ΔNp63α contributing to the effects of LMP2A on epithelial 
differentiation.
Both LMP2A and ΔNp63α have been suggested to have oncogenic potential and are 
associated with epithelial cell malignancies. The effects of LMP2A on ΔNp63α expression 
and stability may be an important contributing factor to the development of EBV associated 
epithelial malignancies including NPC.
Materials and Methods
Differentiation of HaCaT Cells
The human keratinocyte HaCaT cell line was maintained in calcium-free DMEM 
supplemented with 10% heat-inactivated FBS, from which calcium was removed, and 1% 
antibiotic/antimycotic. To remove calcium, Chelex 100 resin (BioRad Laboratories, 
Hercules, CA) was incubated with FBS on a shaker at 4°C for 1 hr (2.5g/50ml) and was 
removed by two sequential vacuum filtrations with a 0.22μm filter. To induce 
differentiation, HaCaT cells were supplemented with 2.8mM CaCl2 for 0 to 120 hours. This 
protocol was adapted from a study investigating HaCaT cells as an in vitro model of 
epithelial cell differentiation (Deyrieux & Wilson, 2007).
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Plasmids and LMP2A-Expressing Cell Lines
Stable HaCaT cell lines expressing the pBabe vector or the pBabe vector subcloned with 
HA-tagged LMP2A, LMP2A Δ PY, LMP2A Δ ITAM, LMP2A Δ YEEA, or with ΔNp63α 
were generated by transduction with recombinant retroviruses expressing each vector and 
selection with 0.5μg/ml puromycin as described previously (Morrison & Raab-Traub, 2005; 
Scholle et al., 2000). The N-terminus of LMP2A contains two PY motifs (aa56-60 and 
aa96-100), one ITAM motif (aa74-88) and one YEEA motif (aa112-115). The LMP2A Δ PY 
mutant contains four proline-alanine mutations at aa57, aa58, aa98, and aa99 to disrupt both 
PY motifs. The LMP2AΔ ITAM mutant contains a tyrosine-phenylalanine mutation at aa74, 
a deletion from aa75-111 and is consequently missing both the ITAM motif and the second 
PY motif. The LMP2A Δ YEEA mutant contains a tyrosine-phenylalanine mutation at 
aa112. The LMP2A mutants were a generous gift from Dr. R. Longnecker.
To stably express ΔNp63α in HaCaT cells, ΔNp63α was subcloned into pBabe from 
pcDNA3-ΔNp63α graciously provided by Dr. M. Oren. HaCaT cells stably over-expressing 
pBabe-ΔNp63α were generated by retroviral transduction and selection with puromycin 
(0.5μg/ml).
HEK293 cells were maintained in DMEM containing 10% FBS and 1% antibiotic/
antimycotic and were transiently transfected for 48 hours using FuGENE with the pBabe 
and pcDNA3 vectors alone, pBabe-LMP-2A, pcDNA3-ΔNp63α (a generous gift from Dr. 
M. Oren), and pBabe-LMP-2A + pcDNA3-ΔNp63α, as per manufacturer’s protocol.
Western Blot and Immunoprecipitation
Whole-cell lysates were generated by lysis of cell pellets with RIPA buffer (50mM Tris-HCl 
pH 7.4, 150mM NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1mM EDTA) and were 
subjected to western blot. For whole cell lysate immunoprecipitation, cell pellets were lysed 
with NETN buffer (0.5% NP-40, 50mM Tris-HCl pH 8.0, 1mM EDTA, 120mM NaCl) and 
were incubated at 4°C overnight with 2–10μg primary antibody (LMP2 or p63α). 50μl 
protein G bead slurry was added for 1 hour, beads were washed 5 times, and bound proteins 
were eluted with sample buffer heated at 95°C for 10 minutes.
RIPA/NETN buffer whole cell lysates and IP lysates were subjected to SDS PAGE, 
transferred to nitrocellulose membranes, blocked for 1 hour in 5% milk/TBS-Tween, and 
incubated overnight with primary antibody diluted in 5% milk/TBS-Tween (mouse anti-Itch 
1:250 BD Biosciences, mouse anti-involucrin 1:1000 Sigma-Aldrich, anti-GRP78 1:200 
Santa Cruz, rabbit anti-GAPDH 1:500 Santa Cruz, goat anti-actin 1:500 Santa Cruz, rabbit 
anti-ΔNp63 1:250 BioLegend, mouse anti-p63α 1:200 Santa Cruz, rat anti-LMP2 clone 
14B7 1:2000 Abcam Inc, mouse anti-keratin 10 1:100 NeoMarkers). Membranes were 
washed and incubated for 1 hour with horseradish peroxidase conjugated secondary 
antibodies (Amersham Biosciences and Dako) diluted 1:1000 in 5% milk/TBS-Tween. 
Western blots were washed and developed with Pierce Supersignal West Pico System. Band 
volumes were measured with ImageJ64 software (National Institutes of Health).
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Cell pellets were isolated and resuspended in 200–300 μl of hypotonic lysis buffer (10 mM 
Hepes (pH 7.6)/10 mM NaCl/1.5 mM MgCl2/0.1% Nonidet P-40/10% glycerol, 0.5 mM 
DDT/0.4 mM PMSF/1 mM NaF/0.1 mM NaVO4/Complete Mini protease inhibitors 
(Roche)). Lysates were incubated on ice for 15 min and centrifuged for 5 min at 1,000 x g 
(4°C). Supernatants were reserved and cell pellets were washed once with 100 μl of 
hypotonic lysis buffer and centrifuged for 5 min at 1,000 x g (4°C). Supernatants were 
combined with the previous supernatant to yield the cytoplasmic fraction.
The nuclear pellets were manually homogenized using a dounce homogenizer with 1mM 
EDTA containing protease inhibitors. Nuclear lysates were centrifuged at 300 x g for 10 min 
at 4°C. The clear supernatant was collected and centrifuged at 20,000 x g for 20 min at 4°C 
to separate the particulate fraction. Supernatants were collected and reserved (nucleoplasm) 
and pellets were resuspended in homogenization buffer (nuclear membranes).
Real-Time Polymerase Chain Reaction
RNA lysis buffer was added to freshly isolated cell pellets and lysates were stored at −80°C 
until extraction. Total RNA was purified fusing the Qiagen RNeasy Plus kit according to the 
manufacturer’s instructions. mRNA expression levels of involucrin, keratin 1, TAp63, 
ΔNp63, and actin were determined using the Qiagen QuantiTech SYBR-green real-time 
PCR kit according to the manufacturer’s instructions and SYBR-green labeled PCR products 
were detected using an Applied Biosystems 7900HT real-time PCR system.
Immunofluorescence
Cells were plated into 8 well permanox-coated chamber slides and were allowed to attach 
overnight. Slides were gently washed with PBS and fixed for 15 minutes with ice-cold 
acetone:methanol (1:1) and blocked for 15 minutes at room temperature with 3% bovine 
serum albumin in PBS. Primary antibodies were prepared in PBS (rat anti-LMP2 clone 4E11 
1:2000, mouse anti-p63α) and incubated for 1 hour at room temperature in a humidified 
chamber. Slides were washed and incubated in a humidified chamber for 1 hour at room 
temperature with secondary antibodies prepared in PBS (anti-rat FITC 1:100, anti-mouse 
Cy3 1:100). Slides were then washed and mounted with glass coverslips using anti-fade 
mounting media. Samples were visualized using an Olympus FV500 confocal laser scanning 
microscope at the Microscopy Services Laboratory at the University of North Carolina, 
Chapel Hill.
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Figure 1. LMP2A Increases Expression and Stability of p63α
A LMP2A, Itch, p63α, and ΔNp63 expression in HaCaT cells stably expressing full-length 
LMP2A and LMP2A mutants PY, ITAM, and YEEA were determined by western blot. 
Actin expression was measured as the loading control. B ΔNp63α protein expression in 
HaCaT cells was determined by western blot and is expressed graphically. Equal loading 
and normalization was measured using an actin-specific antibody. C Endogenous expression 
of the p63 isoforms TAp63 and ΔNp63 in HaCaT cells was determined by SYBR-green 
quantitative RT-PCR. Expression is shown graphically by CT (cycle threshold) indicating 
that ΔNp63 is the predominant isoform in HaCaT cells. D Stability of LMP2A and p63α 
protein levels were determined by inhibiting de novo protein synthesis with 20mM 
cycloheximide for 0–24 hours in HaCaT cells stably expressing pBabe or LMP2A. Cell 
lysates were collected and protein levels of p63α and actin were determined by western blot. 
E p63α protein levels were normalized to actin and expressed relative to time 0 to determine 
turnover rate in HaCaT cells stably expressing pBabe and LMP2A. Time (hrs) indicates 
duration of treatment with 20mM cycloheximide. F pBabe and LMP2A expressing HaCaT 
cells were treated with DMSO or 20μM of the proteasome inhibitor MG132 for 4 hours. 
p63α expression was determined by western blot in whole cell lysates.
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Figure 2. LMP2A Immunoprecipitates with p63α in Cytoplasmic and Nuclear Membrane 
Fractions
A Lysates from HaCaT cells stably expressing pBabe, LMP2A, PY, ITAM, YEEA, and 
ΔNp63α were fractionated into cytoplasmic (cyto - C), nuclear (nuc – N), and nuclear 
membrane (NM) fractions. Protein expression in each fraction was determined by western 
blot. Data is also expressed graphically as % of the total amount of the protein of interest 
detected in each fraction. B Itch (n=4). C p63α (n=3). D LMP2A (n=3). E Localization of 
LMP2A-Itch-p63α complexes in HaCaT cells was determined by immunoprecipitation of 
LMP2A in fractionated lysates followed by western blot for p63α and Itch. LMP2A was 
immunoprecipitated from pBabe (pB) cytoplasmic, and from LMP2A cytoplasmic (C), 
nucleoplasmic (N), and nuclear membrane (NM) fractions. For beads-only controls (B), 
protein G beads were added to pBabe and LMP2A cytoplasmic fractions, without an 
antibody IP, to assess non-specific protein binding.
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Figure 3. LMP2A Associates with p63α in Cytoplasm and Nuclear Membrane and Requires the 
PY and ITAM Signaling Motifs
A Whole cell lysates from HEK293 cells transiently expressing pBabe+pcDNA3, ΔNp63α, 
LMP2A, or LMP2A+ΔNp63α were fractionated into cytoplasmic (cyto - C), nuclear (nuc – 
N), and nuclear membrane (NM) fractions. Protein expression in each fraction was 
determined by western blot. Data is also expressed graphically as % of the total amount of 
the protein of interest that was detected in each fraction. B Itch (Standard deviations were 
calculated based on n=2). C p63α (Standard deviations were calculated based on n=2). D 
LMP2A (n=1). E Localization of LMP2A-p63α-Itch complexes was determined by 
immunoprecipitation of p63α from fractionated lysates (cytoplasmic – C, nucleoplasmic – 
N, nuclear membrane – NM) followed by western blot for LMP2A and Itch. For beads-only 
controls, protein G beads were added to ΔNp63α and ΔNp63α+ LMP2A cytoplasmic 
fractions, without an antibody IP, to determine non-specific protein binding. F Requirement 
of LMP2A signaling motifs for association of LMP2 with p63α was determined by 
immunoprecipitation of LMP2A from HEK293 cells transiently expressing pBabe, LMP2A 
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or the PY, ITAM, or YEEA mutants of LMP2A, followed by western blot for Itch and p63α. 
For beads-only controls, protein G beads were added to LMP2A lysates, without an antibody 
IP, to determine non-specific protein binding.
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Figure 4. LMP2A Expression and Association with p63α is Localized to the Nuclear Membrane
Localization and expression of LMP2A and p63α was determined by immunofluorescence 
in LMP2A and ΔNp63α expressing HEK293 cells (i–iv) and in LMP2A-expressing HaCaT 
cells (v–viii). Co-localization of LMP2A and p63α is indicated in panels iv (yellow – 
HEK293 cells) and viii (yellow – HaCaT cells). Samples were stained with secondary 
antibodies only to determine background staining in HEK293 cells (ix–x) and HaCaT cells 
(xi–xii) and images were acquired with identical exposure times and conditions as in panels 
i–viii. All images were obtained with a 60X oil objective using an Olympus FV500 confocal 
laser scanning microscope.
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Figure 5. LMP2A is Associated with Inhibition of Differentiation Marker Expression
HaCaT cells were induced to de-differentiate in calcium-free culture conditions for 3 weeks. 
A Expression of the differentiation markers involucrin and keratin 10 were determined by 
western blot before and after de-differentiation in calcium-free media (day -5 and day 21, 
respectively). B Expression levels of involucrin and keratin 10 were normalized to GAPDH 
and are represented graphically in the right panel. C,D To evaluate induction of 
differentiation by CaCl2, de-differentiated cells were induced to differentiate in media 
containing 2.8mM CaCl2. Cells were collected and lysed 0, 5, 24, 48, 72, and 96 hours 
following addition of CaCl2. mRNA expression of keratin 1 (C) and involucrin (D) was 
determined by quantitative real-time PCR, was normalized to GAPDH, and is expressed 
relative to time 0. Standard errors were calculated from 3 experiments each run in triplicate. 
E Protein expression of involucrin in HaCaT cells stably expressing pBabe, LMP2A, PY, 
and ΔNp63α induced to differentiate with 2.8mM CaCl2 for 0–120 hours was determined by 
western blot, normalized to actin, and expressed graphically relative to time 0. For each time 
point, involucrin levels were also normalized to involucrin from HaCaT cells allowed to 
proliferate without calcium, in order to determine specific calcium-induced involucrin 
expression. D To determine if LMP2A-induced p63α was associated with epithelial cell 
differentiation, p63α expression was determined by western blot from HaCaT cells before 
(differentiated) and after (de-differentiated) de-differentiation in Ca2+-free media. p63α 
levels were normalized to actin, and are expressed graphically.
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